⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

October 10, 2016Future OncologyOpen Access

Renovated (nondual) approach to endometrial cancer typing: endocrine and inflammatory issues

Lev M. Berstein

View Full Paper

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

endocrine and immune system • endometrial cancer • heterogeneity • immunotherapy and hormonal therapy • low-grade inflammation • mutations • obesity

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Lev M. Berstein (2016) studied this question.

synapsesocial.com/papers/6ab9c3a70a1fc6aea07ece59 https://doi.org/10.2217/fon-2016-0397

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1USA Endometrial Cancer Projections to 2030: Should we be Concerned?Original Research · 2014 · 236 citations
2Progesterone Action in Endometrial Cancer, Endometriosis, Uterine Fibroids, and Breast CancerReview · 2013 · 517 citations
3Insulinemia, heterogeneity of obesity and the risk of different types of endometrial cancer: existing evidenceReview · 2015 · 5 citations
4Hormonal, Metabolic, and Inflammatory Profiles and Endometrial Cancer Risk Within the EPIC Cohort—A Factor AnalysisCohort Study · 2013 · 148 citations
5Whole-exome sequencing combined with functional genomics reveals novel candidate driver cancer genes in endometrial cancerCase-Control Study · 2012 · 241 citations
6Integrated genomic characterization of endometrial carcinomaOriginal Research · 2013 · 5,766 citations
7Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer—Combined Analysis of the PORTEC CohortsPrognostic Study · 2016 · 853 citations
8Polymerase ɛ (<scp><i>POLE</i></scp>) mutations in endometrial cancer: Clinical outcomes and implications for <scp>L</scp>ynch syndrome testingPrognostic Study · 2014 · 174 citations
9Plain language summary: comparing ivonescimab plus chemotherapy with placebo plus chemotherapy in people with advanced EGFR-mutated non–small cell lung cancer (NSCLC) whose disease worsened on EGFR-TKI treatment in the HARMONi studyFuture Oncology · 2026
10Treatment patterns and characteristics of Chinese patients with advanced or resectable melanoma: a multicenter retrospective studyFuture Oncology · 2026

More from Future Oncology

More from Institute of Oncology NN Petrov